
Eurobio Scientific SA
PAR:ALERS

During the last 3 months Eurobio Scientific SA insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 0% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/par/alers/vs/indx/gdaxi">open performance analysis).
The last transaction was made on
Dec 18, 2023
by
Denis Fortier
(General Manager)
, who
bought
7.6k EUR
worth of ALERS shares.
During the last 3 months Eurobio Scientific SA insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 0% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/par/alers/vs/indx/gdaxi">open performance analysis).
The last transaction was made on
Dec 18, 2023
by
Denis Fortier
(General Manager)
, who
bought
7.6k EUR
worth of ALERS shares.
Eurobio Scientific SA
Glance View
Eurobio-Scientific SA engages in designing, development and commercialization of tests diagnosis in the fields of transplantation, infectious diseases, autoimmunity and oncology, as well as products for research in the field of life sciences. The company is headquartered in Les Ulis, Ile-De-France. The company went IPO on 2005-11-18. The company is engaged in activities ranging from discovery to the commercialization of specialty diagnostic products. The firm owns a portfolio of diagnostic products in three specialty areas: infectious diseases; Alzheimer's disease, and cancer. The company consists of Tetanos Quick Stick (TQS), which is an unitary test enabling to determine the tetanus vaccination status. The company has a portfolio of in-house and co-developed products, including AclarusDx (a blood-based test for the detection of biomarkers specific for Alzheimer's disease). The portfolio includes BJI Inoplex for prosthetic infections and EHT Dx14 for breast cancer (both in validation phase). The co-developed products include research programs for the identification of predictive biomarkers of response for anti-HER2 and anti-angiogenic therapies, among others. The company operates through Genbio and Eurobio Capforce Plus.

What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.